Filing Details

Accession Number:
0001209191-10-044738
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-01 17:25:57
Reporting Period:
2010-08-30
Filing Date:
2010-09-01
Accepted Time:
2010-09-01 17:25:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1033905 Luminex Corp LMNX Surgical & Medical Instruments & Apparatus (3841) 742747608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1105966 Ii Walter G Loewenbaum 1708 Windsor
Austin TX 78703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-08-30 10,000 $14.70 971,727 No 4 S Indirect SPOUSE
Common Stock Disposition 2010-08-31 900 $14.49 945,450 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect SPOUSE
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 946,350 Direct
Common Stock 65,000 Indirect PARTNERSHIP
Common Stock 712,043 Indirect TRUSTS
Common Stock 971,727 Indirect SPOUSE
Common Stock 65,000 Indirect PARTNERSHIP
Common Stock 712,043 Indirect TRUSTS
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.6500 to $14.7710 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.4900 to $14.4910 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.